NCT00002291已完成不适用
A Double-Blind Group Comparative Study To Evaluate the Safety and Effectiveness of Three Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCP
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Fisons
- 试验地点
- 2
研究概览
简要总结
To evaluate and compare the safety, tolerability, and efficacy of biweekly administration of 1 of 3 doses of aerosol pentamidine when used as a prophylactic agent in patients who have recovered from their first episode of AIDS-associated Pneumocystis carinii pneumonia (PCP).
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Concurrent Medication:
- •Zidovudine (AZT).
排除标准
- •Co-existing Condition:
- •Patients with the following are excluded:
- •Requiring ongoing active therapy for an opportunistic infection (O.I.) at time of entry or those with either of the following AIDS-defining O.I.'s prior to entry:
- •Toxoplasmosis.
- •Cryptococcosis.
- •Transfusion dependent (requiring blood transfusion more than once per month). The last transfusion cannot have been given within 7 days of study entry.
- •Pulmonary Kaposi's sarcoma (KS).
- •Asthma requiring medication.
- •Active therapy for tuberculosis.
- •Concurrent Medication:
- •Active therapy for tuberculosis.
- •Patients with the following are excluded:
- •Requiring ongoing active therapy for an opportunistic infection (O.I.) at time of entry or those with either of the following AIDS-defining O.I.'s prior to entry:
- •Toxoplasmosis.
- •Cryptococcosis.
- •Transfusion dependent (requiring blood transfusion more than once per month). The last transfusion cannot have been given within 7 days of study entry.
- •Pulmonary Kaposi's sarcoma (KS).
- •Unwilling to sign informed consent.
- •Cannot cooperate with study procedures.
- •Asthma requiring medication.
- •Prior Medication:
- •Excluded within 30 days of study entry:
- •Antiretrovirals other than zidovudine (AZT).
- •Immunomodulating agents.
- •Corticosteroids.
- •Patients must:
- •Have AIDS and recovered from their first episode of cytologically or histologically proven Pneumocystis carinii pneumonia (PCP).
- •Be at least 2 weeks and no more than 24 weeks status post therapy for acute PCP.
- •Have positive antibody to HIV by any federally licensed ELISA test kit, or confirmed Western blot test.
- •Have adequate pulmonary function (vital capacity = or > 80 percent of predicted; forced expiratory volume (FEV), 1 s = or > 65 percent of total FEV; and corrected pulmonary diffusion capacity > 60 percent of predicted).
- •Free of acute medical problems.
- •Active substance abuse.
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCPPneumonia, Pneumocystis CariniiHIV InfectionsNCT00002055Fisons
已完成
2 期
A Study to Evaluate the Efficacy After Allergen Challenge, Safety and Tolerability of Inhaled CHF6001 DPI in AsthmaticsAsthmaNCT01689571Chiesi Farmaceutici S.p.A.36
已完成
不适用
A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's DiseaseParkinson's DiseaseNCT01149811Bausch Health Americas, Inc.27
已完成
3 期
2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)Postoperative Nausea and VomitingNCT00090155Merck Sharp & Dohme LLC805
已完成
3 期
2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091)Postoperative Nausea and VomitingNCT00090246Merck Sharp & Dohme LLC922